Skip to main content
Ravi Kumar Distilleries Limited logo

Ravi Kumar Distilleries Limited — Investor Relations & Filings

Ticker · RKDL ISIN · INE722J01012 BSE.NS Manufacturing
Filings indexed 424 across all filing types
Latest filing 2026-02-10 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS RKDL

About Ravi Kumar Distilleries Limited

http://www.ravikumardistilleries.com/

Ravi Kumar Distilleries Limited specializes in the manufacture, marketing, and distribution of Indian Made Foreign Liquor (IMFL). The company operates a comprehensive distillation and bottling facility, producing a diverse portfolio of spirits including whisky, brandy, rum, vodka, and gin. Its proprietary brand lineup features labels such as Capricorn, Kaveri, 2nd Innings, and Black Pearl. In addition to its own brand operations, the company provides contract manufacturing and bottling services for established liquor brands. The facility utilizes modern distillation technology to ensure quality standards across its product range, catering to regional consumer preferences and wholesale distribution networks.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
Interim / Quarterly Report Classification · 95% confidence The document contains detailed unaudited financial results for the quarter and nine months ended 31st December 2025, including revenue, net profit/loss, EPS, and other financial metrics. It references Regulation 33 and 52 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which govern quarterly financial disclosures. The document is lengthy (15,000 characters) and includes actual financial data and analysis, not just an announcement or a certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). 9M 2026
2026-02-10 English
Outcome of Board Meeting
Regulatory Filings
2026-02-06 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2026-01-31 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a notice from the company to the stock exchanges about an upcoming Board of Directors meeting scheduled for February 6, 2026. The purpose of the meeting is to consider and approve the unaudited financial results for the quarter and nine months ended December 31, 2025. The document also mentions the closure of the trading window for designated persons in compliance with insider trading regulations. The document is short (2160 characters) and serves as an announcement of a future event (board meeting and financial results approval), not the financial results report itself. It is a regulatory announcement related to board meeting scheduling and compliance, fitting the category of Regulatory Filings (RNS) rather than an Interim Report (IR) or Board/Management Information (MANG) since it does not announce any changes in board or management but only the meeting notice.
2026-01-31 English
Updates
Regulatory Filings Classification · 95% confidence The document is a certificate issued pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming compliance for the quarter ended December 31, 2025. It is addressed to stock exchanges and signed by the company secretary and the registrar and transfer agent. The document is short (3655 characters) and primarily serves as a compliance certificate rather than a financial report or detailed filing. It does not contain financial statements, management discussion, or other report content. It is a regulatory compliance certificate, which fits best under Regulatory Filings (RNS) as it is a regulatory announcement and certification rather than a full report or announcement of a report publication.
2026-01-10 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a letter from the company to stock exchanges announcing the closure of the trading window in compliance with insider trading regulations. It references the upcoming announcement of unaudited financial results for the quarter and nine months ended December 31, 2025, but does not contain any financial data or results itself. The document is short (2199 characters) and serves as a regulatory compliance announcement rather than a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS) as a general compliance notification.
2025-12-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.